Learn More
Medchemexpress LLC 7-(morpholin-4-yl)-2,1,3-benzoxadiazol-4-amine | 842964-18-5 | 99.9% | 220.23 g/mol | C10H12N4O2 | 25MG

Supplier: Medchemexpress LLC HY12483225MG
δ-Secretase inhibitor 11 is an orally active, blood-brain barrier-penetrant, selective δ-secretase inhibitor (IC50 = 0.7 μM) developed for Alzheimer's disease research; it reduces tau and APP cleavage and has demonstrated improvement of synaptic function in transgenic mouse models. The compound is supplied as a solid with high research-grade purity and is soluble in DMSO for in vitro use.
- Orally active and blood-brain barrier penetrant.
- Selective δ-secretase inhibition with reported IC50 of 0.7 μM.
- High chemical purity suitable for research (99.9%).
- Soluble in DMSO (~116.7 mg/mL) with ultrasonic assistance.
- Solid form; store at 4°C and protect from light.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.